According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing significant growth owing to the increasing ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Technology Feature Published: July 2010 Next-generation sequencing: adjusting to data overload Monya Baker Nature Methods 7, 495–499 (2010) Cite this article ...

In the current workflow for lung cancer patients, rapid genetic tests are often performed first. These tests use limited tumor tissue and leave about one in four patients without enough material for ...

In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Collaborations between academic and community cancer centers enhance access to care, with success in acute myeloid leukemia and precision oncology.

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

A harrowing new book tells the story of the women determined to learn the fates of the babies born to their pregnant ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...